FOR IMMEDIATE RELEASE: July 11, 2019 CONTACT: Ariela Weinberger, aweinberger@rooseveltinstitute.org Rising Number of Hospital Mergers and Closures in Rural America Hurting Women’s Health, Economic Well-Being Roosevelt Institute documents adverse effects of market power crisis An issue brief released today by the Roosevelt Institute finds that corporate consolidation within America’s rural hospital sector is harming both

Structural problems in the health care and hospital industries are specifically hurting women in rural America, both as patients and as workers. In a new Roosevelt issue brief, Andrea Flynn, Rakeen Mabud, and Emma Chessen explore some of the industry-wide shifts that have occurred in rural areas over the last several decades. They then describe the

Growing up as a Bengali American woman in Arizona, I have repeatedly been left with an unshakable feeling of being an outsider looking in. Belonging to the only Muslim family in my small community, I struggled to relate to my peers. I can recall being forced to navigate a variety of stereotypes and constantly fielding

FOR IMMEDIATE RELEASE: June 19, 2019 CONTACT: Ariela Weinberger, aweinberger@rooseveltinstitute.org The High Cost of Shareholder Power in Big Pharma New Roosevelt brief illustrates the magnitude of Big Pharma spending on shareholders NEW YORK, NY – At a time when Americans pay record prices for medications, pharmaceutical companies generate record profits devoted largely to rewarding shareholders

Despite Big Pharma’s claim that high-cost medicines are the price society must pay for innovation, recent research provides ample evidence that overpriced medicines are not necessary for the industry to find cures or revolutionize. Rather, high-cost and low-quality medicines are the price patients pay for an industry that prioritizes profit-seeking over public health. Like all

In “The Cost of Capture: How the Pharmaceutical Industry Has Corrupted Policymakers and Harmed Patients,” Roosevelt Fellow Julie Margetta Morgan and Advocacy Associate Devin Duffy explore how drug companies influence policymakers and what this means for patients, the American health care system, and our economy. One of a series on Big Pharma, this issue brief

Each Saturday, a Roosevelt staff member will share 3-5 articles that they consider must-reads. This week, Roosevelt Communications Director Kendra Bozarth is sharing an antitrust reading list and elevates the hidden rules of drug addiction. I recently finished Good and Mad by Rebecca Traister, which is fitting because I am definitely a woman signaling fury

FOR IMMEDIATE RELEASE: April 10, 2019 CONTACT: Ariela Weinberger, aweinberger@rooseveltinstitute.org A New 21st Century Policy Agenda: Roosevelt Report Proposes Changing the Balance of Power in the Economy At Washington DC launch event, Roosevelt experts presented a new approach to policymaking, with a keynote from former Georgia House Minority Leader Stacey Abrams WASHINGTON, DC — Today,

FOR IMMEDIATE RELEASE: April 10, 2019 CONTACT: Ariela Weinberger, aweinberger@rooseveltinstitute.org Roosevelt Institute Releases New Policy Report on Tackling 21st Century Economic Challenges New report offers bold approach to policymaking: curbing concentrated power and reclaiming public power in our economy and political system NEW YORK, NY — Today, the Roosevelt Institute, a New York-based think tank

America’s political landscape and economic thinking are shifting. The 2016 election—and the rise of powerful movements over the past decade—has shown us that Americans are calling for change. They want a diagnosis of our economy to help make sense of what’s gone wrong and to suggest ways to make things better. In New Rules for